25446614|t|Compounds blocking methylglyoxal-induced protein modification and brain endothelial injury.
25446614|a|BACKGROUND AND AIMS: Elevated levels of reactive carbonyl species such as methylglyoxal triggers carbonyl stress and activates a series of inflammatory responses leading to accelerated vascular damage. Carbonyl stress is implicated in conditions and diseases like aging, diabetes mellitus, Alzheimer's disease and cardiovascular diseases. Our aim was to examine the effects of methylglyoxal on human hCMEC/D3 brain endothelial cells and search for protective molecules to prevent endothelial damage. METHODS: Methylglyoxal-induced modification of albumin was tested in a cell-free assay. Endothelial cell viability was monitored by impedance measurement in real-time. The following compounds were tested in cell-free and viability assays: beta-alanine, all-trans-retinoic acid, aminoguanidine, ascorbic acid, L-carnosine, GW-3333, indapamide, piracetam, gamma-tocopherol, U0126, verapamil. Barrier function of brain endothelial monolayers was characterized by permeability measurements and visualized by immunohistochemistry for beta-catenin. mRNA expression level of 60 selected blood-brain barrier-related genes in hCMEC/D3 cells was investigated by a custom Taqman gene array. RESULTS: Methylglyoxal treatment significantly elevated protein modification, exerted toxicity, reduced barrier integrity, increased permeability for markers FITC-dextran and albumin and caused higher production of reactive oxygen species in hCMEC/D3 endothelial cells. Changes in the mRNA expression of 30 genes coding tight junction proteins, transporters and enzymes were observed in methylglyoxal-treated hCMEC/D3 cells. From the tested 11 compounds only all-trans-retinoic acid, an antioxidant and antiglycation agent, U0126, a MAP/ERK kinase inhibitor and aminoguanidine attenuated methylglyoxal-induced damage in hCMEC/D3 cells. CONCLUSIONS: All-trans-retinoic acid and inhibition of the MAP/ERK signaling pathway may be protective in carbonyl stress induced brain endothelial damage.
25446614	19	32	methylglyoxal	Chemical	MESH:D011765
25446614	66	90	brain endothelial injury	Disease	MESH:D020214
25446614	132	140	reactive	Chemical	-
25446614	141	157	carbonyl species	Chemical	-
25446614	166	179	methylglyoxal	Chemical	MESH:D011765
25446614	231	243	inflammatory	Disease	MESH:D007249
25446614	277	292	vascular damage	Disease	MESH:D057772
25446614	363	380	diabetes mellitus	Disease	MESH:D003920
25446614	382	401	Alzheimer's disease	Disease	MESH:D000544
25446614	406	429	cardiovascular diseases	Disease	MESH:D002318
25446614	469	482	methylglyoxal	Chemical	MESH:D011765
25446614	486	491	human	Species	9606
25446614	492	500	hCMEC/D3	CellLine	CVCL:U985
25446614	572	590	endothelial damage	Disease	MESH:D014652
25446614	601	614	Methylglyoxal	Chemical	MESH:D011765
25446614	639	646	albumin	Gene	213
25446614	831	843	beta-alanine	Chemical	MESH:D015091
25446614	845	868	all-trans-retinoic acid	Chemical	MESH:D014212
25446614	870	884	aminoguanidine	Chemical	MESH:C004479
25446614	886	899	ascorbic acid	Chemical	MESH:D001205
25446614	914	921	GW-3333	Chemical	MESH:C434456
25446614	923	933	indapamide	Chemical	MESH:D007190
25446614	935	944	piracetam	Chemical	MESH:D010889
25446614	946	962	gamma-tocopherol	Chemical	MESH:D024504
25446614	964	969	U0126	Chemical	MESH:C113580
25446614	971	980	verapamil	Chemical	MESH:D014700
25446614	1121	1133	beta-catenin	Gene	1499
25446614	1209	1217	hCMEC/D3	CellLine	CVCL:U985
25446614	1281	1294	Methylglyoxal	Chemical	MESH:D011765
25446614	1358	1366	toxicity	Disease	MESH:D064420
25446614	1430	1442	FITC-dextran	Chemical	MESH:C015219
25446614	1447	1454	albumin	Gene	213
25446614	1487	1510	reactive oxygen species	Chemical	MESH:D017382
25446614	1514	1522	hCMEC/D3	CellLine	CVCL:U985
25446614	1659	1672	methylglyoxal	Chemical	MESH:D011765
25446614	1681	1689	hCMEC/D3	CellLine	CVCL:U985
25446614	1731	1754	all-trans-retinoic acid	Chemical	MESH:D014212
25446614	1796	1801	U0126	Chemical	MESH:C113580
25446614	1834	1848	aminoguanidine	Chemical	MESH:C004479
25446614	1860	1873	methylglyoxal	Chemical	MESH:D011765
25446614	1892	1900	hCMEC/D3	CellLine	CVCL:U985
25446614	1921	1944	All-trans-retinoic acid	Chemical	MESH:D014212
25446614	1971	1974	ERK	Gene	5594
25446614	2038	2062	brain endothelial damage	Disease	MESH:D020214
25446614	Positive_Correlation	MESH:D011765	MESH:D017382
25446614	Negative_Correlation	MESH:D014212	MESH:D020214
25446614	Negative_Correlation	MESH:D011765	MESH:D014212
25446614	Negative_Correlation	MESH:C113580	MESH:D011765
25446614	Association	MESH:D011765	213
25446614	Positive_Correlation	MESH:D011765	MESH:D007249
25446614	Association	MESH:D020214	5594
25446614	Positive_Correlation	MESH:D011765	MESH:D020214
25446614	Positive_Correlation	MESH:D011765	MESH:D057772
25446614	Positive_Correlation	MESH:C015219	MESH:D011765
25446614	Negative_Correlation	MESH:C004479	MESH:D011765

